Literature DB >> 6129392

Epidermal growth factor, somatostatin, and psoriasis.

G Ghirlanda, L Uccioli, F Perri, L Altomonte, A Bertoli, R Manna, L Frati, A V Greco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6129392     DOI： 10.1016/s0140-6736(83)91594-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Absence of somatostatin receptors in psoriatic skin lesions.

Authors:  J C Reubi; T Hunziker
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Somatostatin in paroxysmal supraventricular and junctional tachycardia.

Authors:  A V Greco; G Ghirlanda; C Barone; A Bertoli; S Caputo; L Uccioli; R Manna
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-07

3.  Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines.

Authors:  G Scambia; P B Panici; G Baiocchi; L Perrone; S Iacobelli; S Mancuso
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

4.  Methodological aspects on immunohistochemistry in dermatology with special reference to neuronal markers.

Authors:  A Ljungberg; O Johansson
Journal:  Histochem J       Date:  1993-10

5.  Analysis of somatostatin receptor subtype mRNA expression in human breast cancer.

Authors:  A A Evans; T Crook; S A Laws; A C Gough; G T Royle; J N Primrose
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.

Authors:  K J O'Byrne; J T Ennis; P J Freyne; L J Clancy; J S Prichard; D N Carney
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.